- Global Pharma News & Resources

Envision Pharma Group scoops two Silvers at the PM Society Digital Awards 2020

London, UK, September 18, 2020

The PM Society Digital Awards 2020 saw Envision pick up two Silver awards for Congress, Meetings & Events and for Innovation – Creativity as a result of its “See through diabetes” work in collaboration with Mundipharma.

Multichannel Director at Envision, Alex Watson, said, “These two Silver awards are another fantastic accolade for Envision. Following our success at the PM Society Awards in 2019, this really is testament to the excellence and consistency that our creative/digital team achieve. Congratulations to our exceptionally talented team that, in close partnership with Mundipharma and supported by Woolley Pau, conceptualized this novel and impactful way to engage a larger audience with this important and valuable message.”

Nick Morgan, Head of Specialist Driven Primary Care, Europe, Mundipharma, added, “We are thrilled that Mundipharma has been recognized for digital excellence in communicating this important message that will help to positively impact the lives of Type 2 Diabetes (T2D) patients everywhere. We put healthcare professionals and the patients they serve at the heart of everything we do, and to be recognized at the PM Society Digital Awards for this project is testament to this. Working with the Envision team to achieve these goals is a true partnership, where our objectives and vision meet the creativity and know-how to produce these exceptional results.”

2020 marks the eleventh year of the PM Society Digital Awards, where the best in digital creativity, innovation, and effectiveness are recognized from across the healthcare industry. The event prides itself on highlighting the best programs, tools, and campaigns across a broad range of digital activities.

Watson also noted, “Digital excellence is not just about employing the latest technology, but ensuring technological solutions support the creative proposition and aid in achieving the core communication objectives.”


About Envision Pharma Group
Founded in 2001, Envision Pharma Group is a global, innovative technology and scientific communications company serving pharmaceutical, biotechnology, and medical device companies. Envision is a leading provider of evidence-based communication services and industry-leading technology solutions (iEnvision®) that have applicability across many areas of medical affairs and related functional responsibility. Envision Pharma Group provides services and technology solutions to more than 90 companies, including all of the top 20 pharmaceutical companies.

Envision has 14 offices: six in the United Kingdom – Bishop’s Stortford, Glasgow, Horsham, London (Battersea and Hammersmith), and Wilmslow; one in Serbia – Subotica; one in Hungary – Szeged; four in the United States – Fairfield and Glastonbury, CT, Philadelphia, PA, Warren, NJ; and two in the Asia-Pacific region – Tokyo and Sydney. The company employs around 800 team members, including over 250 highly qualified and experienced in-house medical writers, and 190 technology solutions team members who provide software development and customer support. To find out more, visit

For further information:

Marsha Caplin
Global Head of Marketing
Envision Pharma Group
Tel: +44 (0)7557 083549

Editor Details

Related Links

Last Updated: 21-Sep-2020